Genomics of Drug Sensitivity in Cancer |
BMS-345541
|
Synonyms |
BMS345541, IKK Inhibitor 3
|
Targets |
IKK1, IKK2
|
Target pathway |
Other, kinases
|
PubCHEM ID |
9813758
|
Jsmol |
|
Download molecule |
9813758
|
PUBCHEM IUPAC INCHI |
InChI=1S/C14H17N5/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18)
|
Smiles |
N2(=C(NCCN)C1(=NC=C(N1C3(=C2C=CC(=C3)C))C))
|
Cluster number |
101
|
calculated LogS |
-4,664
|
Molecular weight |
255,324
|
calculated LogP |
0,8626
|
H-Acceptors |
5
|
H-Donors |
2
|
Ro5 violations |
0
|
Druglikeness |
0,12284
|
DrugScore |
0,585940385522199
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity2 |
1,8085
|
Rat Acute Toxicity |
2,7155
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability2 |
0,1871
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,4018
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Inhibitor
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Inhibitor
|
Subcellular localization |
Nucleus
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-2,8485
|